儿童支气管哮喘诊断与治疗新进展

支气管哮喘是由嗜酸性粒细胞,肥大细胞和淋巴细胞和其他细胞参与形成的气道炎症,气道狭窄患者,呼吸困难,咳嗽,哮喘复发症状。根据世界卫生组织的全球统计,近年来在支气管哮喘患者正在上升,尤其是在儿童支气管哮喘。近年来,随着对临床支气管哮喘疾病的认识程度的加深,许多专家和学者分别从病理学,生理学,免疫学,分子生物学,基因诊断,临床方面作了更全面,更深入的探索和研究。本文将侧重于综合近期在儿童支气管哮喘:诊断和治疗的新进展。

Bronchial asthma is composed of eosinophils,mast cells and T lymphocytes and other cells involved in the formation of airway inflammation,patients with airway stenosis,dyspnea,cough,recurrent wheezing symptoms. According to the WHO global statistics,in recent years in patients with bronchial asthma is rising,especially in children with bronchial asthma. In recent years,along with the clinical on bronchial asthma disease awareness degree deepening,many experts and scholars have separately from the pathology,physiology,immunology,molecular biology,gene diagnosis,clinical aspects were made more comprehensive,more in depth exploration and research. This paper will focus on integrated near future on bronchial asthma in children : diagnosis and treatment of the new progress.